...
首页> 外文期刊>Angewandte Chemie >Selective N-Terminal BET Bromodomain Inhibitors by Targeting Non-Conserved Residues and Structured Water Displacement**
【24h】

Selective N-Terminal BET Bromodomain Inhibitors by Targeting Non-Conserved Residues and Structured Water Displacement**

机译:通过靶向非保守的残留物和结构性水位移选择性N-末端下注溴染色剂**

获取原文
获取原文并翻译 | 示例
           

摘要

Bromodomain and extra-terminal (BET) family proteins, BRD2-4 and T, are important drug targets; however, the biological functions of each bromodomain remain ill-defined. Chemical probes that selectively inhibit a single BET bromodomain are lacking, although pan inhibitors of the first (D1), and second (D2), bromodomain are known. Here, we develop selective BET D1 inhibitors with preferred binding to BRD4 D1. In competitive inhibition assays, we show that our lead compound is 9-33 fold selective for BRD4 D1 over the other BET bromodomains. X-ray crystallography supports a role for the selectivity based on reorganization of a non-conserved lysine and displacement of an additional structured water in the BRD4 D1 binding site relative to our prior lead. Whereas pan-D1 inhibitors displace BRD4 from MYC enhancers, BRD4 D1 inhibition in MM.1S cells is insufficient for stopping Myc expression and may lead to its upregulation. Future analysis of BRD4 D1 gene regulation may shed light on differential BET bromodomain functions.
机译:溴多胺和外末端(BET)家族蛋白BRD2-4和T是重要的药物靶点;然而,每一种溴化物的主要生物学功能仍然不明确。虽然已知第一种(D1)和第二种(D2)溴代多巴胺的pan抑制剂,但缺乏选择性抑制单一BET溴代多巴胺的化学探针。在这里,我们开发了选择性的BET D1抑制剂,优先与BRD4 D1结合。在竞争抑制试验中,我们发现我们的先导化合物对BRD4 D1的选择性是其他BET溴代二烯的9-33倍。X射线晶体学支持基于非保守赖氨酸重组和BRD4 D1结合位点相对于我们之前的铅的额外结构水置换的选择性作用。pan-D1抑制剂取代了MYC增强子中的BRD4,而BRD4-D1抑制剂在MM中的作用更为明显。1S细胞不足以阻止Myc表达,并可能导致其上调。未来对BRD4 D1基因调控的分析可能会揭示其主要功能的差异。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号